[144] Quest Diagnostics Inc. SEC Filing
Quest Diagnostics (DGX) filed a Form 144 reporting a proposed sale of 1,903 common shares through Fidelity Brokerage Services (900 Salem Street, Smithfield, RI) with an approximate aggregate market value of $342,54008/15/2025. The filing lists total shares outstanding as 111,823,441. The document also discloses a recent sale by Thomas P. Plewman of 5,535 common shares on 08/06/2025 for gross proceeds of $968,625. The record of acquisition shows numerous small purchases and vesting events (ESPP purchases, dividend reinvestments, restricted stock vesting) between 02/01/2021 and 06/28/2024 that underlie the holdings to be sold.
Quest Diagnostics (DGX) ha presentato un Form 144 per segnalare la proposta vendita di 1.903 azioni ordinarie tramite Fidelity Brokerage Services (900 Salem Street, Smithfield, RI), per un valore di mercato complessivo approssimativo di $342.540 e con data di vendita indicativa 15/08/2025. Il deposito riporta un totale di azioni in circolazione pari a 111.823.441. Il documento riporta inoltre una recente vendita da parte di Thomas P. Plewman di 5.535 azioni ordinarie avvenuta il 06/08/2025 per proventi lordi di $968.625. Il registro degli acquisti evidenzia numerosi piccoli acquisti e eventi di maturazione (acquisti ESPP, reinvestimenti dei dividendi, maturazione di azioni vincolate) tra il 01/02/2021 e il 28/06/2024 che costituiscono le partecipazioni soggette alla vendita.
Quest Diagnostics (DGX) present贸 un Form 144 informando de la propuesta de venta de 1.903 acciones ordinarias a trav茅s de Fidelity Brokerage Services (900 Salem Street, Smithfield, RI), con un valor de mercado agregado aproximado de $342.540 y una fecha de venta indicada del 15/08/2025. La presentaci贸n indica un total de acciones en circulaci贸n de 111.823.441. El documento tambi茅n revela una venta reciente por parte de Thomas P. Plewman de 5.535 acciones ordinarias el 06/08/2025 por ingresos brutos de $968.625. El historial de adquisiciones muestra numerosas compras peque帽as y eventos de consolidaci贸n (compras ESPP, reinversi贸n de dividendos, consolidaci贸n de acciones restringidas) entre el 01/02/2021 y el 28/06/2024 que sustentan las participaciones a vender.
Quest Diagnostics(DGX)電� Form 144毳� 鞝滌稖頃橃棳 Fidelity Brokerage Services(900 Salem Street, Smithfield, RI)毳� 韱淀暣 1,903 氤错喌欤茧ゼ 毵る弰頃� 鞓堨爼鞛勳潉 氤搓碃頄堨溂氅�, 雽�霝� 齑� 鞁滉皜鞎� $342,540 氚� 鞓堨爼 毵る弰鞚� 2025-08-15毳� 旮办灛頄堨姷雼堧嫟. 鞝滌稖靹滊鞐愲姅 氚滍枆 欤检嫕 齑濎垬臧� 111,823,441欤茧 氇呾嫓霅橃柎 鞛堨姷雼堧嫟. 氍胳劀鞐愲姅 霕愴暅 Thomas P. Plewman鞚� 2025-08-06鞐� 5,535 氤错喌欤茧ゼ 毵る弰頃橃棳 齑濎垬鞚� $968,625毳� 鞏混棃雼る姅 斓滉芳 毵る弰 雮挫棴霃� 瓿奠嫓霅橃柎 鞛堨姷雼堧嫟. 旆摑 旮半鞐愲姅 2021-02-01攵�韯� 2024-06-28 靷澊鞚� 雼れ垬鞚� 靻岅窚氇� 毵れ垬 氚� 甓岆Μ 頇曥爼 鞚措菠韸�(ESPP 毵れ垬, 氚半嫻 鞛埇鞛�, 鞝滍暅欤� 氩犾姢韺�)臧� 毵る弰 雽�靸� 氤挫湢攵勳潣 攴缄卑搿� 旮办灛霅橃柎 鞛堨姷雼堧嫟.
Quest Diagnostics (DGX) a d茅pos茅 un Form 144 signalant la proposition de vente de 1 903 actions ordinaires via Fidelity Brokerage Services (900 Salem Street, Smithfield, RI), pour une valeur de march茅 agr茅g茅e approximative de $342 540 et une date de vente indiqu茅e au 15/08/2025. Le dossier indique un nombre total d'actions en circulation de 111 823 441. Le document r茅v猫le 茅galement une vente r茅cente de Thomas P. Plewman de 5 535 actions ordinaires le 06/08/2025 pour un produit brut de $968 625. Le registre des acquisitions montre de nombreux petits achats et 茅v茅nements de consolidation (achats ESPP, r茅investissements de dividendes, lev茅es d'actions restreintes) entre le 01/02/2021 et le 28/06/2024 qui sous-tendent les participations concern茅es par la vente.
Quest Diagnostics (DGX) hat ein Formular 144 eingereicht, in dem ein geplanter Verkauf von 1.903 Stammaktien 眉ber Fidelity Brokerage Services (900 Salem Street, Smithfield, RI) gemeldet wird, mit einem ungef盲hren Gesamtmarktwert von $342.540 und einem angegebenen voraussichtlichen Verkaufsdatum 15.08.2025. Die Einreichung gibt die insgesamt ausstehenden Aktien mit 111.823.441 an. Das Dokument offenbart au脽erdem einen k眉rzlichen Verkauf durch Thomas P. Plewman von 5.535 Stammaktien am 06.08.2025 mit Bruttoerl枚sen von $968.625. Die Erwerbsaufzeichnung zeigt zahlreiche kleinere K盲ufe und Vesting-Ereignisse (ESPP-K盲ufe, Dividendenreinvestitionen, Vesting von Restricted Stock) zwischen dem 01.02.2021 und dem 28.06.2024, die den zu verkaufenden Bestand begr眉nden.
- Transparent disclosure of proposed insider sale in compliance with Rule 144
- Detailed acquisition history showing shares were acquired via ESPP, dividend reinvestment, and restricted stock vesting
- Insider selling reported: proposed sale of 1,903 shares (aggregate value $342,540) and recent sale of 5,535 shares for $968,625
Insights
TL;DR: This Form 144 reports routine insider selling and prior recent sales; the amounts disclosed are modest relative to a large-cap issuer.
The filing notifies the market of a proposed sale of 1,903 common shares via Fidelity with an aggregate market value of $342,540 and records a recent sale of 5,535 shares by Thomas P. Plewman for $968,625. The acquisition history is composed mainly of ESPP purchases, dividend reinvestments, and periodic restricted stock vesting events, indicating routine compensation and employee share-purchase activity rather than a single large grant being monetized. From an investor-impact perspective, the filing is a disclosure of insider liquidity activity; it does not, by itself, provide evidence of material company-specific developments.
TL;DR: The notice shows compliance with Rule 144 disclosure for an insider sale and documents the provenance of shares through standard employee programs.
The Form 144 documents the seller's representation that no material nonpublic information exists and enumerates how the securities were acquired (ESPP, dividends, vesting). The granular acquisition schedule supports that the shares are and were acquired through customary compensation and purchase plans. No information in the filing indicates regulatory, governance, or control changes. This appears to be routine insider liquidity with appropriate disclosure filed.
Quest Diagnostics (DGX) ha presentato un Form 144 per segnalare la proposta vendita di 1.903 azioni ordinarie tramite Fidelity Brokerage Services (900 Salem Street, Smithfield, RI), per un valore di mercato complessivo approssimativo di $342.540 e con data di vendita indicativa 15/08/2025. Il deposito riporta un totale di azioni in circolazione pari a 111.823.441. Il documento riporta inoltre una recente vendita da parte di Thomas P. Plewman di 5.535 azioni ordinarie avvenuta il 06/08/2025 per proventi lordi di $968.625. Il registro degli acquisti evidenzia numerosi piccoli acquisti e eventi di maturazione (acquisti ESPP, reinvestimenti dei dividendi, maturazione di azioni vincolate) tra il 01/02/2021 e il 28/06/2024 che costituiscono le partecipazioni soggette alla vendita.
Quest Diagnostics (DGX) present贸 un Form 144 informando de la propuesta de venta de 1.903 acciones ordinarias a trav茅s de Fidelity Brokerage Services (900 Salem Street, Smithfield, RI), con un valor de mercado agregado aproximado de $342.540 y una fecha de venta indicada del 15/08/2025. La presentaci贸n indica un total de acciones en circulaci贸n de 111.823.441. El documento tambi茅n revela una venta reciente por parte de Thomas P. Plewman de 5.535 acciones ordinarias el 06/08/2025 por ingresos brutos de $968.625. El historial de adquisiciones muestra numerosas compras peque帽as y eventos de consolidaci贸n (compras ESPP, reinversi贸n de dividendos, consolidaci贸n de acciones restringidas) entre el 01/02/2021 y el 28/06/2024 que sustentan las participaciones a vender.
Quest Diagnostics(DGX)電� Form 144毳� 鞝滌稖頃橃棳 Fidelity Brokerage Services(900 Salem Street, Smithfield, RI)毳� 韱淀暣 1,903 氤错喌欤茧ゼ 毵る弰頃� 鞓堨爼鞛勳潉 氤搓碃頄堨溂氅�, 雽�霝� 齑� 鞁滉皜鞎� $342,540 氚� 鞓堨爼 毵る弰鞚� 2025-08-15毳� 旮办灛頄堨姷雼堧嫟. 鞝滌稖靹滊鞐愲姅 氚滍枆 欤检嫕 齑濎垬臧� 111,823,441欤茧 氇呾嫓霅橃柎 鞛堨姷雼堧嫟. 氍胳劀鞐愲姅 霕愴暅 Thomas P. Plewman鞚� 2025-08-06鞐� 5,535 氤错喌欤茧ゼ 毵る弰頃橃棳 齑濎垬鞚� $968,625毳� 鞏混棃雼る姅 斓滉芳 毵る弰 雮挫棴霃� 瓿奠嫓霅橃柎 鞛堨姷雼堧嫟. 旆摑 旮半鞐愲姅 2021-02-01攵�韯� 2024-06-28 靷澊鞚� 雼れ垬鞚� 靻岅窚氇� 毵れ垬 氚� 甓岆Μ 頇曥爼 鞚措菠韸�(ESPP 毵れ垬, 氚半嫻 鞛埇鞛�, 鞝滍暅欤� 氩犾姢韺�)臧� 毵る弰 雽�靸� 氤挫湢攵勳潣 攴缄卑搿� 旮办灛霅橃柎 鞛堨姷雼堧嫟.
Quest Diagnostics (DGX) a d茅pos茅 un Form 144 signalant la proposition de vente de 1 903 actions ordinaires via Fidelity Brokerage Services (900 Salem Street, Smithfield, RI), pour une valeur de march茅 agr茅g茅e approximative de $342 540 et une date de vente indiqu茅e au 15/08/2025. Le dossier indique un nombre total d'actions en circulation de 111 823 441. Le document r茅v猫le 茅galement une vente r茅cente de Thomas P. Plewman de 5 535 actions ordinaires le 06/08/2025 pour un produit brut de $968 625. Le registre des acquisitions montre de nombreux petits achats et 茅v茅nements de consolidation (achats ESPP, r茅investissements de dividendes, lev茅es d'actions restreintes) entre le 01/02/2021 et le 28/06/2024 qui sous-tendent les participations concern茅es par la vente.
Quest Diagnostics (DGX) hat ein Formular 144 eingereicht, in dem ein geplanter Verkauf von 1.903 Stammaktien 眉ber Fidelity Brokerage Services (900 Salem Street, Smithfield, RI) gemeldet wird, mit einem ungef盲hren Gesamtmarktwert von $342.540 und einem angegebenen voraussichtlichen Verkaufsdatum 15.08.2025. Die Einreichung gibt die insgesamt ausstehenden Aktien mit 111.823.441 an. Das Dokument offenbart au脽erdem einen k眉rzlichen Verkauf durch Thomas P. Plewman von 5.535 Stammaktien am 06.08.2025 mit Bruttoerl枚sen von $968.625. Die Erwerbsaufzeichnung zeigt zahlreiche kleinere K盲ufe und Vesting-Ereignisse (ESPP-K盲ufe, Dividendenreinvestitionen, Vesting von Restricted Stock) zwischen dem 01.02.2021 und dem 28.06.2024, die den zu verkaufenden Bestand begr眉nden.
FAQ
What does Quest Diagnostics' (DGX) Form 144 report?
Who conducted a recent sale reported in the filing?
Through which broker will the proposed DGX shares be sold?
What is the provenance of the shares to be sold?
How many Quest Diagnostics shares are outstanding per the filing?
